Specifically, AGR3 promotes tamoxifen resistance in breast cancer [31], SRGN is a key molecule in mediating chemoresistance and stemness in breast cancer cells [30], and PPP1R1B is involved in resistance of breast cancer cells to trastuzumab [32]. This evidence concerns the gene PPP1R1B and breast cancer.